| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| rp174096-500μg | 500μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,334.90 | |
| rp174096-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,334.90 |
| Product Name | galectin 9, CAS No.rp174096 |
|---|---|
| Grade | Moligand™ |
| Specifications & Purity | Moligand™ |
| CAS | rp174096 |
|---|
| 1. Hirashima M. (1999) Ecalectin as a T cell-derived eosinophil chemoattractant.. Int Arch Allergy Immunol, 120 Suppl 1 (13): (7-10). [PMID:10529594] [10.1021/op500134e] |
| 2. Hirashima M. (2000) Ecalectin/galectin-9, a novel eosinophil chemoattractant: its function and production.. Int Arch Allergy Immunol, 122 Suppl 1 (13): (6-9). [PMID:10867499] [10.1021/op500134e] |
| 3. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA et al.. (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.. Nature, 415 (6871): (536-41). [PMID:11823861] [10.1021/op500134e] |
| 4. Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN. (2002) Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge.. J Biol Chem, 277 (17): (14916-24). [PMID:11839756] [10.1021/op500134e] |
| 5. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T. (2004) Galectin-9 in physiological and pathological conditions.. Glycoconj J, 19 (7-9): (593-600). [PMID:14758084] [10.1021/op500134e] |
| 6. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.. Nat Immunol, 6 (12): (1245-52). [PMID:16286920] [10.1021/op500134e] |
| 7. Heusschen R, Freitag N, Tirado-González I, Barrientos G, Moschansky P, Muñoz-Fernández R, Leno-Durán E, Klapp BF, Thijssen VL, Blois SM. (2013) Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.. Biol Reprod, 88 (1): (22). [PMID:23242525] [10.1021/op500134e] |
| 8. Heusschen R, Schulkens IA, van Beijnum J, Griffioen AW, Thijssen VL. (2014) Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis.. Biochim Biophys Acta, 1842 (2): (284-92). [PMID:24333696] [10.1021/op500134e] |
| 9. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M. (1998) Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes.. J Biol Chem, 273 (27): (16976-84). [PMID:9642261] [10.1021/op500134e] |
